# Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease

> **NCT05262829** · NA · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **BIOLOGICAL:** Human Umbilical Cord Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT05262829
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-28
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05262829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05262829, "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05262829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*